Delivery Order SPE2DB20D3505-SPE2DB25FU8E3
Award Date
6/16/25
Potential Completion Date
7/9/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has a ceiling value of $2,458.82 and a completion date of June 26, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $2,458.82 and a performance period through June 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 fixed-price contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a completion date of July 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $2,458.82 and a period of performance through July 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $7,376.46 and a performance period extending through May 28, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. As a prime contractor,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm-fixed-price contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a ceiling value of $4,917.64 and a completion date of January 29, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $4,917.64 and a performance period through July 3, 2025. The contract is a Firm Fixed Price, Delivery Order contract, and is not set aside for any special designation. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $2,458.82 and a period of performance through July 3, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific type of business. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a ceiling value of $2,458.82 and a period of performance through July 9, 2025. The contract is a firm-fixed-price delivery order, and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...